<?xml version="1.0" encoding="UTF-8"?>
<ref id="B36">
 <label>36.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Baldo</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Galanis</surname>
    <given-names>E</given-names>
   </name>
   <name>
    <surname>Tangy</surname>
    <given-names>F</given-names>
   </name>
   <name>
    <surname>Herman</surname>
    <given-names>P</given-names>
   </name>
  </person-group>. 
  <article-title>Biosafety considerations for attenuated measles virus vectors used in virotherapy and vaccination</article-title>. 
  <source>Hum Vaccin Immunother.</source> (
  <year>2016</year>) 
  <volume>12</volume>:
  <fpage>1102</fpage>â€“
  <lpage>16</lpage>. 
  <pub-id pub-id-type="doi">10.1080/21645515.2015.1122146</pub-id>
  <?supplied-pmid 26631840?>
  <pub-id pub-id-type="pmid">26631840</pub-id>
 </mixed-citation>
</ref>
